Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technical problems related to multidrug therapy in leprosy control.

H Sansarricq1

  • 1Saint-Armou, Moorlaas, France.

Acta Leprologica
|January 1, 1989
PubMed
Summary

Multidrug therapy (MDT) for leprosy is safe, well-tolerated, and highly effective. Current WHO-recommended MDT regimens show negligible relapse rates, supporting their continued use without modification for leprosy control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What strategy against leprosy?

International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association·2002
Same author

Leprosy elimination--urgent action required.

International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association·1999
Same author

Eliminating leprosy as a public health problem--is the optimism justified?

World health forum·1996
Same author

[The Congress in Yaoundé].

Acta leprologica·1996
Same author

Some points on the elimination of leprosy.

Leprosy review·1994
Same author

A case of relapse with drug-susceptible M. leprae after multidrug therapy.

International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association·1991

Area of Science:

  • Medical Science
  • Infectious Diseases
  • Public Health

Background:

  • Leprosy remains a significant global health concern.
  • Multidrug therapy (MDT) was introduced by the World Health Organization (WHO) in 1981 as the standard treatment.
  • Approximately 40% of registered leprosy patients have received or are receiving MDT.

Purpose of the Study:

  • To evaluate the safety, tolerability, and efficacy of WHO-recommended MDT regimens for leprosy.
  • To assess the long-term outcomes of MDT treatment in leprosy patients.
  • To provide recommendations for the continuation of current MDT strategies.

Main Methods:

  • Analysis of extensive clinical experience with MDT regimens.
  • Review of patient data regarding treatment acceptance and adverse events.
  • Observation of post-therapeutic relapse rates in both multibacillary and paucibacillary leprosy over 1-3 years.

Main Results:

  • WHO-recommended MDT regimens are non-toxic and demonstrate excellent patient acceptance.
  • Post-therapeutic relapse rates following MDT have been negligible in observed patient cohorts.
  • Efficacy data supports the sustained effectiveness of MDT for both multibacillary and paucibacillary leprosy.

Conclusions:

  • Current MDT regimens are a safe and effective cornerstone of global leprosy control.
  • The established WHO MDT protocols should be maintained without modification.
  • Continued adherence to MDT is crucial for achieving and sustaining leprosy elimination goals.

Related Experiment Videos